21 C.F.R. § 807.90 Format of a premarket notification submission.
Title 21 - Food and Drugs
Each premarket notification submission pursuant to this part shall be submitted in accordance with this section. Each submission shall: (a)(1) For devices regulated by the Center for Devices and Radiological Health, be addressed to the Food and Drug Administration, Center for Devices and Radiological Health (HFZ–401), 9200 Corporate Blvd., Rockville, MD 20850. (2) For devices regulated by the Center for Biologics Evaluation and Research, be addressed to the Document Control Center (HFM–99), Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852–1448; or for devices regulated by the Center for Drug Evaluation and Research, be addressed to the Central Document Room, Center for Drug Evaluation and Research, Food and Drug Administration, 5901–B Ammendale Rd., Beltsville, MD 20705–1266. Information about devices regulated by the Center for Biologics Evaluation and Research is available at http://www.fda.gov/cber/dap/devlst.htm on the Internet. (3) All inquiries regarding a premarket notification submission should be in writing and sent to one of the addresses above. (b) Be bound into a volume or volumes, where necessary. (c) Be submitted in duplicate on standard size paper, including the original and two copies of the cover letter. (d) Be submitted separately for each product the manufacturer intends to market. (e) Designated “510(k) Notification” in the cover letter. [42 FR 42526, Aug. 23, 1977, as amended at 53 FR 11252, Apr. 6, 1988; 55 FR 11169, Mar. 27, 1990; 65 FR 17137, Mar. 31, 2000; 70 FR 14986, Mar. 24, 2005]
Title 21: Food and Drugs
PART 807—ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL IMPORTERS OF DEVICES
Subpart E—Premarket Notification Procedures
§ 807.90 Format of a premarket notification submission.
